These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 9638321)
1. Identification and development of new biopharmaceuticals. Werner RG Arzneimittelforschung; 1998 May; 48(5):523-30. PubMed ID: 9638321 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Biopharmaceuticals in China. Hu X; Ma Q; Zhang S Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435 [TBL] [Abstract][Full Text] [Related]
5. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
6. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes]. Zhang DL; Ji L; Li YD Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601 [TBL] [Abstract][Full Text] [Related]
7. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
8. Transgenic plants as factories for biopharmaceuticals. Giddings G; Allison G; Brooks D; Carter A Nat Biotechnol; 2000 Nov; 18(11):1151-5. PubMed ID: 11062432 [TBL] [Abstract][Full Text] [Related]
9. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones. Workman P Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933 [TBL] [Abstract][Full Text] [Related]
10. Cancer Drug Development: New Targets for Cancer Treatment. Curt GA Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic applications of genetic engineering]. Descamps JL Ann Pharm Fr; 1994; 52(6):294-302. PubMed ID: 7864529 [TBL] [Abstract][Full Text] [Related]
13. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
14. Biopharmaceuticals derived from genetically modified plants. Goldstein DA; Thomas JA QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527 [TBL] [Abstract][Full Text] [Related]
15. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives. Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585 [TBL] [Abstract][Full Text] [Related]
16. Alternative strategies in drug development: clinical pharmacological aspects. Kuhlmann J Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic success via targeted approaches and strategic partnerships with clinical laboratories. Miller GA IDrugs; 2007 Mar; 10(3):181-4. PubMed ID: 17351872 [TBL] [Abstract][Full Text] [Related]
18. Antibody engineering: facing new challenges in cancer therapy. Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728 [TBL] [Abstract][Full Text] [Related]
19. Creating the next generation of protein therapeutics through rational drug design. Szymkowski DE Curr Opin Drug Discov Devel; 2005 Sep; 8(5):590-600. PubMed ID: 16159021 [TBL] [Abstract][Full Text] [Related]
20. [New horizons for medicine on the basis of genetic technology]. Werner RG Arzneimittelforschung; 1995 Sep; 45(9):1040-7. PubMed ID: 7488308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]